This study is to evaluate which cognitive-linguistic symptoms are most commonly experienced following brain tumor treatment. Cognitive surveys will be administered after treatment of primary brain tumor cancer.

Inclusion Criteria:

• be between18 to 89 years old;
• have undergone at least one cycle of a cancer treatment regimen (e.g., chemotherapy, radiotherapy, surgery)
• have completed at least one cycle of a cancer treatment regimen within five years of enrollment in the study;
• be native speakers of American English;
• have obtained a minimum of a high school education;
• self-report at least one cognitive-linguistic or social-emotional deficit as assessed by the FACT-BR; and
• must demonstrate capacity to sign informed consent based on Informed Consent for Research: A Guide to Assessing a Participant's Understanding tool.

Exclusion Criteria:

• are younger than 18 years old or older than 89 years old;
• have not undergone at least one cycle of a cancer treatment regimen following diagnosis (e.g., chemotherapy, radiotherapy, surgery)
• have not undergone at least one cycle of a cancer treatment regimen in the five year period prior to enrollment;
• are not native speakers of American English;
• have not obtained a minimum of a high school education;
• do not self-report at least one cognitive-linguistic or social-emotional deficit as assessed by the FACT-BR; or
• do not demonstrate the capacity to sign informed consent

adults diagnosed with a malignant brain tumor either as a primary diagnosis or recurrent